Vor Biopharma (VOR) Current Assets (2020 - 2026)
Vor Biopharma (VOR) posted quarterly Current Assets of $500.8 million for Q1 2026, up 672.25% year-over-year from $64.8 million in Q1 2025, and up 9.32% quarter-over-quarter from $458.1 million in Q4 2025.
Vor Biopharma (VOR) Current Assets (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has reported Current Assets for 7 consecutive years, with $500.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets rose 672.25% year-over-year to $500.8 million; the TTM figure through Mar 2026 stood at $500.8 million (up 672.25% YoY), while the FY2025 annual figure was $458.1 million, up 374.69% from the prior year.
- Current Assets advanced to $500.8 million in Q1 2026 per VOR's latest filing, from $458.1 million in the prior quarter.
- Across five years, Current Assets topped out at $500.8 million in Q1 2026 and bottomed at $64.8 million in Q1 2025.
- Historically, Current Assets has averaged $188.8 million across 5 years, with a median of $164.4 million in 2023.
- Annual changes were most pronounced in 2024 — Current Assets sank 59.08% — and 2026, when it soared 672.25%.
- Vor Biopharma's Current Assets stood at $237.0 million in 2022, then plunged by 40.58% to $140.8 million in 2023, then plunged by 31.46% to $96.5 million in 2024, then jumped by 374.69% to $458.1 million in 2025, then rose by 9.32% to $500.8 million in 2026.
- Business Quant data shows VOR's Current Assets at $500.8 million in Q1 2026, $458.1 million in Q4 2025, and $172.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Vor Biopharma | 1.36 Bn | 1.36 Bn | - | 475.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 475.11 Mn |
| Mar 31, 2026 | 500.78 Mn |
| Dec 31, 2025 | 458.11 Mn |
| Sep 30, 2025 | 172.49 Mn |
| Jun 30, 2025 | 204.93 Mn |
| Mar 31, 2025 | 64.85 Mn |
| Dec 31, 2024 | 96.51 Mn |
| Sep 30, 2024 | 67.30 Mn |
| Jun 30, 2024 | 90.26 Mn |
| Mar 31, 2024 | 111.82 Mn |
| Dec 31, 2023 | 140.80 Mn |
| Sep 30, 2023 | 164.44 Mn |
| Jun 30, 2023 | 191.39 Mn |
| Mar 31, 2023 | 216.90 Mn |
| Dec 31, 2022 | 236.95 Mn |
| Sep 30, 2022 | 142.73 Mn |
| Jun 30, 2022 | 158.84 Mn |
| Mar 31, 2022 | 190.30 Mn |
| Dec 31, 2021 | 214.40 Mn |
| Sep 30, 2021 | 232.07 Mn |